98 related articles for article (PubMed ID: 17258176)
1. Anionic phospholipids inhibit apolipoprotein E--low-density lipoprotein receptor interactions.
Yamamoto T; Ryan RO
Biochem Biophys Res Commun; 2007 Mar; 354(3):820-4. PubMed ID: 17258176
[TBL] [Abstract][Full Text] [Related]
2. Replacement of helix 1' enhances the lipid binding activity of apoE3 N-terminal domain.
Redmond KA; Murphy C; Narayanaswami V; Kiss RS; Hauser P; Guigard E; Kay CM; Ryan RO
FEBS J; 2006 Feb; 273(3):558-67. PubMed ID: 16420479
[TBL] [Abstract][Full Text] [Related]
3. A two-module region of the low-density lipoprotein receptor sufficient for formation of complexes with apolipoprotein E ligands.
Fisher C; Abdul-Aziz D; Blacklow SC
Biochemistry; 2004 Feb; 43(4):1037-44. PubMed ID: 14744149
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E-low density lipoprotein receptor binding: study of protein-protein interaction in rationally selected docked complexes.
Prévost M; Raussens V
Proteins; 2004 Jun; 55(4):874-84. PubMed ID: 15146486
[TBL] [Abstract][Full Text] [Related]
5. Role of leucine zipper motif in apoE3 N-terminal domain lipid binding activity.
Yamamoto T; Ryan RO
Biochim Biophys Acta; 2006 Sep; 1761(9):1100-6. PubMed ID: 16945585
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E isoform-specific binding to the low-density lipoprotein receptor.
Yamamoto T; Choi HW; Ryan RO
Anal Biochem; 2008 Jan; 372(2):222-6. PubMed ID: 17923100
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the lipid binding properties of the N-terminal domain of human apolipoprotein E3.
Weers PM; Narayanaswami V; Ryan RO
Eur J Biochem; 2001 Jul; 268(13):3728-35. PubMed ID: 11432739
[TBL] [Abstract][Full Text] [Related]
8. Characterization of low density lipoprotein receptor ligand interactions by fluorescence resonance energy transfer.
Yamamoto T; Lamoureux J; Ryan RO
J Lipid Res; 2006 May; 47(5):1091-6. PubMed ID: 16467279
[TBL] [Abstract][Full Text] [Related]
9. Swapping the N- and C-terminal domains of human apolipoprotein E3 and AI reveals insights into their structure/activity relationship.
Lek MT; Cruz S; Ibe NU; Beck WHJ; Bielicki JK; Weers PMM; Narayanaswami V
PLoS One; 2017; 12(6):e0178346. PubMed ID: 28644829
[TBL] [Abstract][Full Text] [Related]
10. Structure-guided protein engineering modulates helix bundle exchangeable apolipoprotein properties.
Kiss RS; Weers PM; Narayanaswami V; Cohen J; Kay CM; Ryan RO
J Biol Chem; 2003 Jun; 278(24):21952-9. PubMed ID: 12684504
[TBL] [Abstract][Full Text] [Related]
11. Structural characterization of a low density lipoprotein receptor-active apolipoprotein E peptide, ApoE3-(126-183).
Raussens V; Mah MK; Kay CM; Sykes BD; Ryan RO
J Biol Chem; 2000 Dec; 275(49):38329-36. PubMed ID: 10986285
[TBL] [Abstract][Full Text] [Related]
12. Cellular sphingolipids regulate macrophage apolipoprotein E secretion.
Lucic D; Huang ZH; Gu D; Subbaiah PV; Mazzone T
Biochemistry; 2007 Oct; 46(39):11196-204. PubMed ID: 17760463
[TBL] [Abstract][Full Text] [Related]
13. A monomeric, biologically active, full-length human apolipoprotein E.
Zhang Y; Vasudevan S; Sojitrawala R; Zhao W; Cui C; Xu C; Fan D; Newhouse Y; Balestra R; Jerome WG; Weisgraber K; Li Q; Wang J
Biochemistry; 2007 Sep; 46(37):10722-32. PubMed ID: 17715945
[TBL] [Abstract][Full Text] [Related]
14. Structural analysis of lipoprotein E particles.
Schneeweis LA; Koppaka V; Lund-Katz S; Phillips MC; Axelsen PH
Biochemistry; 2005 Sep; 44(37):12525-34. PubMed ID: 16156664
[TBL] [Abstract][Full Text] [Related]
15. Characterization of an apolipoprotein E3 variant (Arg 145-->His) associated with mild hypertriglyceridemia.
Hidaka H; Tozuka M; Hidaka E; Yamauchi K; Ota H; Honda T; Katsuyama T
Ann Clin Lab Sci; 2001 Apr; 31(2):163-70. PubMed ID: 11337906
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E LDL receptor-binding domain-containing high-density lipoprotein: a nanovehicle to transport curcumin, an antioxidant and anti-amyloid bioflavonoid.
Khumsupan P; Ramirez R; Khumsupan D; Narayanaswami V
Biochim Biophys Acta; 2011 Jan; 1808(1):352-9. PubMed ID: 20851099
[TBL] [Abstract][Full Text] [Related]
17. Contributions of domain structure and lipid interaction to the functionality of exchangeable human apolipoproteins.
Saito H; Lund-Katz S; Phillips MC
Prog Lipid Res; 2004 Jul; 43(4):350-80. PubMed ID: 15234552
[TBL] [Abstract][Full Text] [Related]
18. The complex of the insect LDL receptor homolog, lipophorin receptor, LpR, and its lipoprotein ligand does not dissociate under endosomal conditions.
Roosendaal SD; Kerver J; Schipper M; Rodenburg KW; Van der Horst DJ
FEBS J; 2008 Apr; 275(8):1751-66. PubMed ID: 18331356
[TBL] [Abstract][Full Text] [Related]
19. Helix orientation of the functional domains in apolipoprotein e in discoidal high density lipoprotein particles.
Narayanaswami V; Maiorano JN; Dhanasekaran P; Ryan RO; Phillips MC; Lund-Katz S; Davidson WS
J Biol Chem; 2004 Apr; 279(14):14273-9. PubMed ID: 14739281
[TBL] [Abstract][Full Text] [Related]
20. Heparin protects against septic mortality via apoE-antagonism.
Chuang KI; Leung B; Hsu N; Harris HW
Am J Surg; 2011 Sep; 202(3):325-35. PubMed ID: 21741028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
